US Markets
Home›US Markets›M&A & Deals›Procter & Gamble to buy Thorne in a $3.8 billion all-c…
Procter & Gamble to buy Thorne in a $3.8 billion all-cash deal
The acquisition is aimed at accelerating growth in P&G's Personal Health Care unit, with Thorne targeting $650 million in revenue for 2026.
Procter & Gamble agreed to acquire Thorne, a premium wellness and dietary supplement maker, in a definitive $3.8 billion all-cash transaction, according to Yahoo Finance. The deal follows shares extending gains on Aug. 4 after the announcement.
P&G is buying the business from private equity firm L Catterton, and the company expects the move to scale its Personal Health Care division in the health and self-care market. Yahoo Finance reported that Thorne generated over $500 million in revenue last year and is targeting $650 million in 2026.
The acquisition would also add Thorne's science-backed nutritional supplements, personalized health solutions, and wellness technology to P&G's portfolio. Yahoo Finance said Thorne's premium brand mix is intended to support higher profit margins than traditional consumer packaged goods.
Yahoo Finance added that the transaction expands P&G's access to health-conscious consumers under age 40, and that P&G plans to leverage its global distribution and retail relationships to grow Thorne’s reach. The outlet also noted P&G’s dividend yield is 2.94%.